# Bioton signs distribution deal for Biomed-Lublin's Distreptaza

Biomed-Lublin signed a distribution agreement with Bioton for the sale of Distreptaza in Poland, valued at approximately PLN 45 million, valid until end of 2022. Biomed also announced a new production line for Distreptaza will start in Q3 2018.

- Type: Contract
- Announced: 2018-02-13
- Where: Poland
- Value: $13.0M (45.0M PLN)
- Status: announced
- Products: Distreptaza (pharmaceutical)

## Companies

- [Biomed-Lublin](https://endata.com/companies/30018.md) (customer)
- [Bioton](https://endata.com/companies/30019.md) (supplier)

## Sources

- [rp.pl](https://www.rp.pl/biznes/art2121791-bioton-dystrybutorem-leku-biomedu), 2018-02-13: "Zainwestowaliśmy w uruchomienie nowego wydziału Distreptazy, co umożliwi nam podwojenie jej produkcji oraz obniży koszty jej wytwarzania"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.